Skip to main content

Table 1 Mercury (μg/L), lead (μg/dl), GST (μmol/l) and vitamin E (nmol/L) levels in the control & autistic groups

From: A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders

Parameters

Group

N

Mean ± S.D.

P valuea

P valueb

Mercury (μg/L)

Control

32

5.12 ± 0.83

  
 

Patients with autism

58

6.99 ± 0.94

 

0.001

 

Autism (mild to moderate in CARS)

29

6.49 ± 0.65

0.042

0.001

 

Autism (severe in CARS)

28

7.31 ± 0.49

0.001

 

Autism (mild to moderate in SRS)

22

7.02 ± 0.85

0.050

0.001

 

Autism (severe in SRS)

22

7.46 ± 0.59

0.001

Lead (μg/dl)

Control

32

4.73 ± 0.67

  
 

Patients with autism

58

6.79 ± 0.97

 

0.001

 

Autism (mild to moderate in CARS)

29

6.34 ± 0.82

0.041

0.001

 

Autism (severe in CARS)

28

6.80 ± 0.83

 

0.001

 

Autism (mild to moderate in SRS)

22

6.42 ± 0.84

0.040

0.001

 

Autism (severe in SRS)

22

6.95 ± 0.81

 

0.001

GST (μmol/min/ml)

Control

30

0.61 ± 0.17

  
 

Patients with autism

30

0.30 ± 0.08

 

0.001

 

Autism (mild to moderate in CARS)

18

0.31 ± 0.07

0.043

0.001

 

Autism (severe in CARS)

12

0.26 ± 0.07

0.001

 

Autism (mild to moderate in SRS)

8

0.32 ± 0.07

0.027

0.001

 

Autism (severe in SRS)

18

0.25 ± 0.06

0.001

Vitamin E (nmol/L)

Control

27

25.44 ± 2.62

  
 

Patients with autism

28

14.45 ± 2.28

 

0.001

 

Autism (mild to moderate in CARS)

11

14.56 ± 1.58

0.048

0.001

 

Autism (severe in CARS)

17

13.36 ± 1.47

0.001

 

Autism (mild to moderate in SRS)

11

14.85 ± 1.36

0.044

0.001

 

Autism (severe in SRS)

12

13.35 ± 1.14

0.001

  1. aP value between mild to moderate and severe in CARS and SRS.
  2. bP value between control and autistic groups.